SI-BONE Inc.
15.63
-0.60 (-3.70%)
At close: Jan 14, 2025, 3:59 PM
15.70
0.45%
After-hours Jan 14, 2025, 04:00 PM EST
undefined%
Bid 6.28
Market Cap 655.49M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.91
PE Ratio (ttm) -17.18
Forward PE n/a
Analyst Buy
Ask 25
Volume 386,065
Avg. Volume (20D) 362,275
Open 16.32
Previous Close 16.23
Day's Range 14.83 - 16.34
52-Week Range 11.70 - 21.64
Beta undefined

About SIBN

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section...

Sector Healthcare
IPO Date Oct 17, 2018
Employees 344
Stock Exchange NASDAQ
Ticker Symbol SIBN

Analyst Forecast

According to 6 analyst ratings, the average rating for SIBN stock is "Buy." The 12-month stock price forecast is $22, which is an increase of 40.75% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

SI-BONE Inc. is scheduled to release its earnings on Feb 24, 2025, during market hours.
Analysts project revenue of $46.89M, reflecting a 20.67% YoY growth and earnings per share of -0.14, making a -48.15% decrease YoY.
1 day ago · Source
+18.29%
SI-BONE shares are trading higher after the compan... Unlock content with Pro Subscription
2 months ago · Source
-15.93%
SI-BONE shares are trading lower after the company reported mixed Q3 financial results and narrowed its FY24 revenue guidance.